Related references
Note: Only part of the references are listed.Chemometric QSAR modeling and in silico design of carbonic anhydrase inhibition of a coral secretory isoform by sulfonamide
Shalini Singh et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
QSARs on human carbonic anhydrase VA and VB inhibitors of some new not yet synthesized, substituted aromatic/heterocyclic sulphonamides as anti-obesity agent
Shalini Singh et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2012)
A QSAR Study on Novel Series of Carbonic Anhydrase Inhibitors hCA IX-Tumor-Associated (Hypoxia)
Shalini Singh
MEDICINAL CHEMISTRY (2012)
A Comparative Molecular Field (CoMFA) Studies on Carbonic Anhydrase Inhibitor hCA IX-Tumor-Associated (Hypoxia)
Shalini Singh
LETTERS IN DRUG DESIGN & DISCOVERY (2011)
Modeling of novel HIV-1 protease inhibitors incorporating N-Aryl-oxazolidinone-5-carboxamides as P2 ligands using quantum chemical and topological finger print descriptors
Shalini Singh et al.
MEDICINAL CHEMISTRY RESEARCH (2011)
Carbonic anhydrase inhibitors
Claudiu T. Supuran
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active β-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c
Fabrizio Carta et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
QSAR studies for the inhibition of the transmembrane carbonic anhydrase isozyme XIV with sulfonamides using PRECLAV software
Shalini Singh et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2009)
Carbonic Anhydrase Inhibitors. Cloning, Characterization, and Inhibition Studies of a New β-Carbonic Anhydrase from Mycobacterium tuberculosis
Isao Nishimori et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis
Christopher Dye
NATURE REVIEWS MICROBIOLOGY (2009)
A QSAR Study on Some Series of Sodium and Potassium Channel Blockers
Lakshman Saini et al.
MEDICINAL CHEMISTRY (2009)
Hyper-Recombination, Diversity, and Antibiotic Resistance in Pneumococcus
William Paul Hanage et al.
SCIENCE (2009)
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
NATURE REVIEWS DRUG DISCOVERY (2008)
Emerging drugs for active tuberculosis
Ann M. Ginsberg
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment
H. D. Hollis Showalter et al.
TUBERCULOSIS (2008)
Recent advances in antituberculous drug development and novel drug targets
Haruaki Tomioka et al.
Expert Review of Respiratory Medicine (2008)
Association of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia
Manjunath P. Pai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants
HF Tsai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Structural mechanics of the pH-dependent activity of β-carbonic anhydrase from Mycobacterium tuberculosis
AS Covarrubias et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Structure and function of carbonic anhydrases from Mycobacterium tuberculosis
AS Covarrubias et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis
JE Bennett et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Carbonic anhydrase inhibitors
CT Supuran et al.
MEDICINAL RESEARCH REVIEWS (2003)